Bronchiolitis obliterans in systemic lupus erythematosus: beneficial effect of intravenous cyclophosphamide

Ann Rheum Dis. 1991 Dec;50(12):956-8. doi: 10.1136/ard.50.12.956.

Abstract

A 49 year old white woman with systemic lupus erythematosus and bronchiolitis obliterans was treated with prednisone (1 mg/kg daily), which led to a transitory improvement in pulmonary status. Cyclophosphamide was then added--4 mg/kg daily intravenously for five days, then 2 mg/kg daily orally--and this was followed by a dramatic and prolonged improvement.

Publication types

  • Case Reports

MeSH terms

  • Administration, Oral
  • Bronchiolitis Obliterans / complications
  • Bronchiolitis Obliterans / drug therapy*
  • Cyclophosphamide / administration & dosage*
  • Cyclophosphamide / therapeutic use
  • Drug Therapy, Combination
  • Female
  • Humans
  • Injections, Intravenous
  • Lupus Erythematosus, Systemic / complications*
  • Lupus Erythematosus, Systemic / drug therapy
  • Middle Aged
  • Prednisolone / therapeutic use

Substances

  • Cyclophosphamide
  • Prednisolone